News

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds
Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...
C&EN3d
DNA-Based Nanostructured Platforms as Drug Delivery Systems
DNA nanotechnology has recently provided a novel approach for developing safe, biocompatible, biodegradable, non-immunogenic, and non-toxic drug delivery systems. DNA nanostructures have numerous ...
Nurix Therapeutics, Inc.: Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and ...
Survivors of death cap mushroom poisoning are rare. This man lived to tell the tale
Simon Claringbold picked and ate wild mushrooms from his garden. Days later, he thought he was taking his last breath.
4basebio Plc - Director Appointment, Board Change
Plc - Director Appointment, Board Change PR Newswire LONDON, United Kingdom, July 08 8 July 20254basebio PLC("4basebio" or the "Company")Director Appointment, Board ...